Consistent Biochemical Data are Essential for Comparability of Botulinum Toxin Type A Products
نویسندگان
چکیده
منابع مشابه
Consistent Biochemical Data are Essential for Comparability of Botulinum Toxin Type A Products
The recent article from Dr Frevert of Merz, together with the accompanying commentary from Dr Sesardic of NIBSC, makes a new contribution to the data available for clinical botulinum toxin type A (BoNT-A) products. However, in addition to the comments about the various technical aspects of the data provided by Dr Frevert, as described by Dr Sesardic, one important and key factor about the BoNT-...
متن کاملBotulinum toxin products overview.
The tremendous success of botulinum toxin type A (BOTOX(R), Allergan Inc.) in the cosmetic arena has acted as a stimulus for the development of other neurotoxins. After more than 2 decades of use, BOTOX(R) has become synonymous with wrinkle reduction and is considered to be the one of the most common non-surgical cosmetic procedures performed worldwide. Because of its vast popularity among pati...
متن کاملBotulinum toxin type A products are not interchangeable: a review of the evidence
Botulinum toxin type A (BoNTA) products are injectable biologic medications derived from Clostridium botulinum bacteria. Several different BoNTA products are marketed in various countries, and they are not interchangeable. Differences between products include manufacturing processes, formulations, and the assay methods used to determine units of biological activity. These differences result in ...
متن کاملBotulinum Toxin Type A on an Intranasal Sponge for Chronic Allergic Rhinitis: Randomized Clinical Trial
Objectives: In this study, we examined the effect of botulinum toxin A (BTA) on chronic allergic rhinitis (CAR). We tested the effects of BTA, applied to an intranasal sponge, on patients who had CAR for a minimum of three years and had been treated unsuccessfully with conventional medications. Methods:The study was an interventional case-control single-blind randomized clinical trial. Forty...
متن کاملBotulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
BACKGROUND Botulinum toxin type B (BTX-B; Myobloc) has recently been introduced for the treatment of dynamic rhytides. This serotype is structurally similar to botulinum toxin type A (BTX-A; Botox) and appears to produce equivalent muscular paralysis. Because of the fact that some patients may become resistant to the effects of BTX-A with its continued use or may require large doses of type A t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Drugs in R & D
سال: 2011
ISSN: 1174-5886,1179-6901
DOI: 10.1007/bf03259798